|
|
 |
 |
MULTIPLE SCLEROSIS · RESEARCH

 |
 |
 |

Questions and answers on the review of Tysabri (natalizumab)
 The European Medicines Agency has completed a review of Tysabri (natalizumab) at the request of the European Commission, following concerns over the safety of the medicine. more ... |
 |
 |
|
 |
 |
|
|
|
 |
|
 |